no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
Adjuvant HPV vaccination for anal cancer prevention in HIV-positive men who have sex with men: The time is now
|
Deshmukh, Ashish A. |
|
2017 |
35 |
38 |
p. 5102-5109 |
article |
2 |
An LASV GPC pseudotyped virus based reporter system enables evaluation of vaccines in mice under non-BSL-4 conditions
|
Li, Qianqian |
|
2017 |
35 |
38 |
p. 5172-5178 |
article |
3 |
A protein chimera including PspA in fusion with PotD is protective against invasive pneumococcal infection and reduces nasopharyngeal colonization in mice
|
Converso, T.R. |
|
2017 |
35 |
38 |
p. 5140-5147 |
article |
4 |
A suicidal strain of Listeria monocytogenes is effective as a DNA vaccine delivery system for oral administration
|
Sinha, Shubhra |
|
2017 |
35 |
38 |
p. 5115-5122 |
article |
5 |
A synthetic human cytomegalovirus pp65-IE1 fusion antigen efficiently induces and expands virus specific T cells
|
Link, Ellen K. |
|
2017 |
35 |
38 |
p. 5131-5139 |
article |
6 |
Benefits of flu vaccination for persons with diabetes mellitus: A review
|
Goeijenbier, M. |
|
2017 |
35 |
38 |
p. 5095-5101 |
article |
7 |
Broadened immunity and protective responses with emulsion-adjuvanted H5 COBRA-VLP vaccines
|
Allen, James D. |
|
2017 |
35 |
38 |
p. 5209-5216 |
article |
8 |
Challenges in immunisation service delivery for refugees in Australia: A health system perspective
|
Mahimbo, A. |
|
2017 |
35 |
38 |
p. 5148-5155 |
article |
9 |
Editorial Board/Aims and Scope
|
|
|
2017 |
35 |
38 |
p. IFC |
article |
10 |
Extracting general practice data for timely vaccine coverage estimates: The England experience
|
Edelstein, Michael |
|
2017 |
35 |
38 |
p. 5110-5114 |
article |
11 |
Immunogenicity and safety of a booster dose of the 13-valent pneumococcal conjugate vaccine in children primed with the 10-valent or 13-valent pneumococcal conjugate vaccine in the Czech Republic and Slovakia
|
Urbancikova, Ingrid |
|
2017 |
35 |
38 |
p. 5186-5193 |
article |
12 |
Impact of rotavirus vaccination on rotavirus and all-cause gastroenteritis in peri-urban Kenyan children
|
Wandera, Ernest Apondi |
|
2017 |
35 |
38 |
p. 5217-5223 |
article |
13 |
Oral cholera vaccine coverage in hard-to-reach fishermen communities after two mass Campaigns, Malawi, 2016
|
Sauvageot, Delphine |
|
2017 |
35 |
38 |
p. 5194-5200 |
article |
14 |
Plasma cell and serum antibody responses to influenza vaccine in preterm and full-term infants
|
D'Angio, Carl T. |
|
2017 |
35 |
38 |
p. 5163-5171 |
article |
15 |
Protective effects of high-potency FMDV O1 Manisa monovalent vaccine in cattle challenged with FMDV O/SKR/2010 at 7 or 4 days post vaccination
|
Horsington, Jacquelyn |
|
2017 |
35 |
38 |
p. 5179-5185 |
article |
16 |
Raw starch microparticles have immunostimulant activity in mice vaccinated with BCG and challenged with Mycobacterium tuberculosis
|
Moreno-Mendieta, Silvia |
|
2017 |
35 |
38 |
p. 5123-5130 |
article |
17 |
Recombinant Calponin of human filariid Brugia malayi: Secondary structure and immunoprophylactic potential
|
Verma, Shiv K. |
|
2017 |
35 |
38 |
p. 5201-5208 |
article |
18 |
Targeting a global health problem: Vaccine design and challenges for the control of tick-borne diseases
|
de la Fuente, José |
|
2017 |
35 |
38 |
p. 5089-5094 |
article |
19 |
The Typhoid Vaccine Acceleration Consortium (TyVAC): Vaccine effectiveness study designs: Accelerating the introduction of typhoid conjugate vaccines and reducing the global burden of enteric fever. Report from a meeting held on 26–27 October 2016, Oxford, UK
|
Meiring, James E. |
|
2017 |
35 |
38 |
p. 5081-5088 |
article |
20 |
Vaccinations in the first year of life and risk of atopic disease – Results from the KiGGS study
|
Schlaud, Martin |
|
2017 |
35 |
38 |
p. 5156-5162 |
article |